Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Teligent Debt to Equity Ratio 2010-2021 | TLGT

Current and historical debt to equity ratio values for Teligent (TLGT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Teligent debt/equity for the three months ending June 30, 2021 was 0.00.
  
Teligent Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2021-06-30 $0.13B $-0.04B -3.08
2021-03-31 $0.13B $-0.03B -4.12
2020-12-31 $0.20B $-0.11B -1.80
2020-09-30 $0.23B $-0.04B -5.75
2020-06-30 $0.23B $-0.04B -6.04
2020-03-31 $0.22B $-0.03B -6.87
2019-12-31 $0.21B $-0.01B -39.99
2019-09-30 $0.20B $0.00B -1266.76
2019-06-30 $0.19B $0.01B 28.11
2019-03-31 $0.18B $0.01B 17.77
2018-12-31 $0.17B $0.02B 9.36
2018-09-30 $0.16B $0.04B 4.40
2018-06-30 $0.15B $0.04B 3.83
2018-03-31 $0.14B $0.04B 3.49
2017-12-31 $0.14B $0.05B 3.13
2017-09-30 $0.14B $0.05B 2.85
2017-06-30 $0.14B $0.06B 2.36
2017-03-31 $0.13B $0.06B 2.26
2016-12-31 $0.13B $0.06B 2.23
2016-09-30 $0.13B $0.06B 2.03
2016-06-30 $0.12B $0.06B 1.94
2016-03-31 $0.12B $0.07B 1.83
2015-12-31 $0.11B $0.07B 1.71
2015-09-30 $0.12B $0.07B 1.58
2015-06-30 $0.12B $0.08B 1.61
2015-03-31 $0.15B $0.05B 3.30
2014-12-31 $0.16B $0.04B 4.04
2014-09-30 $0.02B $0.03B 0.45
2014-06-30 $0.01B $0.01B 0.96
2014-03-31 $0.01B $0.01B 0.85
2013-12-31 $0.01B $0.01B 1.15
2013-09-30 $0.01B $0.01B 0.95
2013-06-30 $0.01B $0.01B 0.77
2013-03-31 $0.00B $0.01B 0.70
2012-12-31 $0.00B $0.01B 0.47
2012-09-30 $0.00B $0.01B 0.46
2012-06-30 $0.00B $0.01B 0.31
2012-03-31 $0.00B $0.01B 0.31
2011-12-31 $0.00B $0.01B 0.24
2011-09-30 $0.00B $0.01B 0.19
2011-06-30 $0.00B $0.01B 0.17
2011-03-31 $0.00B $0.01B 0.17
2010-12-31 $0.00B $0.01B 0.10
2010-09-30 $0.00B $0.00B 0.27
2010-06-30 $0.00B $0.01B 0.28
2010-03-31 $0.00B $0.01B 0.25
2009-12-31 $0.00B $0.01B 0.21
2009-09-30 $0.00B $0.01B 0.20
2009-06-30 $0.00B $0.01B 0.21
2009-03-31 $0.01B $0.00B 1.66
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.440B 5.21
Dr Reddy's Laboratories (RDY) India $12.040B 19.04
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.408B 0.00
Bausch Health Cos (BHC) Canada $3.088B 2.41
Amphastar Pharmaceuticals (AMPH) United States $1.963B 13.44
Supernus Pharmaceuticals (SUPN) United States $1.626B 0.00
Taysha Gene Therapies (TSHA) United States $0.460B 0.00
Generation Bio (GBIO) United States $0.187B 0.00
Assembly Biosciences (ASMB) United States $0.072B 0.00
Personalis (PSNL) United States $0.064B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00